【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Overview of generics
• Generic drugs industry
• Comparison between generic drugs and branded drugs
PART 06: Key leading countries
• US
• China
• India
PART 07: Global pharmaceutical market
• Market overview
• Market size and forecast
PART 08: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 09: Market segmentation by category
• Simple generics
• Super generics
• Biosimilars
PART 10: Market segmentation by therapeutic application
PART 11: Geographical segmentation
• Global generic drugs market by geographical segmentation 2015-2020
• Generic drugs market in Americas
• Generic drugs market in APAC
• Generic drugs market in EMEA
PART 12: Market drivers
• Patent expiry of top-selling drugs
• Growing acceptance of generic medicines
• Increasing demand in emerging markets
• Social and private health insurance in emerging markets
• Increasing prevalence of diseases
PART 13: Impact of drivers
PART 14: Market challenges
• Adverse effects
• Stringent regulations
• Threat of counterfeit drugs
• Intense competition among vendors
PART 15: Impact of drivers and challenges
PART 16: Market trends
• M&A
• Outsourcing of drug development
• Strategic alliances
PART 17: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• Teva Pharmaceuticals
• Sandoz
• Allergan
• Mylan
• Sun Pharmaceuticals
• STADA Arzneimittel
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Advantages and features of generic drugs
Exhibit 03: Value chain of generic pharmaceuticals
Exhibit 04: Regulatory bodies and associations for generic drugs in US and Europe
Exhibit 05: Types of drug application
Exhibit 06: Difference between unbranded, branded, and company-branded generics
Exhibit 07: Comparison between generic and branded drugs
Exhibit 08: Key leading countries in the global generic drugs market
Exhibit 09: Major drivers, challenges, and trends in generic drugs market in US
Exhibit 10: Major drivers, challenges, and trends in generic drugs market in China
Exhibit 11: Major drivers, challenges, and trends in generic drugs market in India
Exhibit 12: Global pharmaceutical market 2015-2020 ($ trillions)
Exhibit 13: Drivers, challenges, and trends in global pharmaceutical market
Exhibit 14: Global pharmaceutical and generic drugs market 2015 ($ billions)
Exhibit 15: Global generic drugs market 2015-2020 ($ billions)
Exhibit 16: Distribution of global medicine spending 2015
Exhibit 17: Five forces analysis
Exhibit 18: Global generic drugs market segmentation by category
Exhibit 19: Global biosimilars market 2015-2020 ($ billions)
Exhibit 20: Global generic drugs market segmentation by therapeutic application
Exhibit 21: Global generic drugs market segmentation by therapeutic application 2015
Exhibit 22: Global generic drugs market by geographical segmentation 2015
Exhibit 23: Global generic drugs market revenue by geographical segmentation 2015-2020 ($ billions)
Exhibit 24: Generic drugs market in Americas 2015-2020 ($ billions)
Exhibit 25: Generic drugs market in Americas by country 2015
Exhibit 26: Distribution of medicine spending in North America 2014
Exhibit 27: Distribution of medicine spending in Central and South America 2014
Exhibit 28: Generic drugs market in US 2015-2020 ($ billions)
Exhibit 29: Overview of generic drugs market in US
Exhibit 30: Regulations in US generic drugs market
Exhibit 31: Generic drugs market in APAC 2015-2020 ($ billions)
Exhibit 32: Distribution of medicine spending in APAC 2015
Exhibit 33: Generic drugs market in APAC by country 2015
Exhibit 34: Generic drugs market in China 2015-2020 ($ billions)
Exhibit 35: Generic drugs market in China 2015-2020 ($ billions)
Exhibit 36: Generic drugs market in India 2015-2020 ($ billions)
Exhibit 37: Generic drugs market in India 2015-2020 ($ billions)
Exhibit 38: Regulation in Indian generic drugs market
Exhibit 39: Generic drugs market in Japan 2015-2020 ($ billions)
Exhibit 40: YoY revenue and growth of the global generics drugs market by geography 2015-2020 ($ billions)
Exhibit 41: Generic drugs market in EMEA 2015-2020 ($ billions)
Exhibit 42: Distribution of medicine spending in Africa and Middle East 2015
Exhibit 43: Generic drugs market in Europe 2015-2020 ($ billions)
Exhibit 44: Overview of generic drugs market in Europe
Exhibit 45: Regulations in generic drugs market in Europe
Exhibit 46: Distribution of medicine spending in Europe 2014
Exhibit 47: Generic drugs market in Europe by country 2015
Exhibit 48: Generic drugs market in Germany 2015-2020 ($ billions)
Exhibit 49: Generic drugs market in the UK 2015-2020 ($ billions)
Exhibit 50: Generic drugs market in France 2015-2020 ($ billions)
Exhibit 51: Generic drugs market in Spain 2015-2020 ($ billions)
Exhibit 52: Generic drugs market in Italy 2015-2020 ($ billions)
Exhibit 53: Patent expiry of branded drugs by 2020
Exhibit 54: Impact of drivers
Exhibit 55: Impact of drivers and challenges
Exhibit 56: Global generic drugs market share analysis 2015
Exhibit 57: Top-10 global generic drug manufacturers by market share 2014
Exhibit 58: Teva Pharmaceuticals: Business segmentation by revenue 2014
Exhibit 59: Teva Pharmaceuticals: YoY growth rate and revenue of generic medicines segment 2012-2014 ($ billions)
Exhibit 60: Teva Pharmaceuticals: Geographic segmentation by revenue 2014 (generic medicines segment)
Exhibit 61: Teva Pharmaceuticals: YoY growth rate and revenue of Copaxone 2012-2014 ($ billions)
Exhibit 62: Teva Pharmaceuticals: YoY growth rate and revenue of Azilect 2012-2014 ($ millions)
Exhibit 63: Teva Pharmaceuticals: SWOT analysis
Exhibit 64: Sandoz: Business segmentation by revenue 2014
Exhibit 65: Sandoz: YoY revenue of retail generics segments 2013-2014 ($ billions)
Exhibit 66: Sandoz: SWOT analysis
Exhibit 67: Allergan: Business segmentation by revenue 2014
Exhibit 68: Allergan: YoY growth rate and revenue of North American generics and international segment 2012-2014 ($ billions)
Exhibit 69: Allergan: Geographic segmentation by revenue 2014 (North American generics and international segment)
Exhibit 70: Allergan: YoY revenue of Lo Loestrin Fe 2013-2014 ($ millions)
Exhibit 71: Allergan: SWOT analysis
Exhibit 72: Mylan: Business segmentation 2014 by revenue
Exhibit 73: Mylan: YoY growth rate and revenue of generics segment 2012-2014 ($ billion)
Exhibit 74: Mylan: Geographical segmentation by revenue 2014 (generics segment)
Exhibit 75: Mylan: SWOTS analysis
Exhibit 76: Sun Pharmaceuticals: Business segmentation by revenue 2014
Exhibit 77: Sun Pharmaceuticals: Geographical segmentation by revenue 2014
Exhibit 78: Sun Pharmaceuticals: SWOT analysis
Exhibit 79: STADA Arzneimittel: Business segmentation by revenue 2014
Exhibit 80: STADA Arzneimittel: YoY growth rate and revenue of generics segment 2012-2014 ($ billions)
Exhibit 81: STADA Arzneimittel: Geographical segmentation by revenue 2014 (generics segment)
Exhibit 82: STADA Arzneimittel: YoY growth rate and revenue of Omeprazole 2012-2014 ($ millions)
Exhibit 83: STADA Arzneimittel: YoY growth rate and revenue of Diclofenac 2012-2014 ($ millions)
Exhibit 84: STADA Arzneimittel: YoY revenue of Tilidine 2013-2014 ($ millions)
Exhibit 85: STADA Arzneimittel: YoY growth rate and revenue of Phospholipide 2013-2014 ($ millions)
Exhibit 86: STADA Arzneimittel: SWOT analysis
【レポート販売概要】
■ タイトル：ジェネリック医薬品の世界市場2016-2020■ 英文：Global Generic Drugs Market 2016-2020
■ 発行日：2016年5月26日
■ 調査会社：Technavio
■ 商品コード：IRTNTR9573
■ 調査対象地域：グローバル
- 母線（バスバー）の世界市場動向・予測2021：銅、アルミニウムThe global busbar market is projected to grow at a CAGR of 5.48% from 2016 to 2021, to reach a size of USD 16.55 Billion by 2021. This growth is attributed to rising energy consumption due to increasing urbanization & industrialization, increasing focus on energy efficiency, and cost & operational benefits of busbar over cables. The report segments the busbar market based on end-user into commerci …
- 世界の調味料、ドレッシング及びソース市場動向：企業M&A（2014年5月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global seasonings, dressings & sauces market during May 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global seasonings, dressings & sauces market throughout the month. Additionally, the repor …
- UK Hospital Tumor Marker Testing Market 2014This new report from Venture Planning Group contains 527 pages, 37 tables, and presents a comprehensive analysis of the UK hospital tumor marker testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Mortali …
- 世界の臨床化学及び免疫診断検査市場：課題、新技術、競争環境“New Frontiers in Point-of-Care/POC Clinical Chemistry and Immunodiagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group’s new report, which provides comprehensive analysis of the POC clinical chemistry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and …
- 麻酔ガスモニタリング装置の世界市場2016-2020Governments in developed and developing countries are giving importance to patient safety during surgical procedures and treatment. To offer better quality care, the governments are providing support by offering reimbursement, which is increasing adoption of advanced anesthesia medical devices. Safe clinical practice on inhalation of anesthesia gases and control over the volatile anesthetic gas de …
- 世界のM2M衛星通信市場動向及び予測(2014 – 2019)Machine-to machine (M2M) market represents an interesting and potentially huge revenue stream for the satellite industry. Terrestrial network currently covers only 10% of the world, and has created a need to switch toward satellite networks which would help to cover the remaining 90% of the world, making it the most attractive aspect of satellite M2M connectivity. This report highlights in detail …
- 世界の癌バイオマーカー市場動向（2012-2016）TechNavio's analysts forecast the Global Cancer Biomarkers market to grow at a CAGR of 18.22 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Cancer Biomarkers market has also been witnessing the trend of the emergence of personalized medicines. However, the poor regulatory and reimbursement systems coul …
- 骨セメントの世界市場About Bone CementBone cement, which is chemically known as polymethyl methacrylate (PMMA), is widely used for implant fixation in various orthopedic and trauma surgeries, as well as, in interventional procedures. Bone cement is available in three types: low, medium, and high viscosity bone cement. Technavio’s analysts forecast the global bone cement market to grow at a CAGR of 6.67% during the per …
- 殺生物剤の世界市場：ハロゲン化合物、金属化合物、有機硫黄化合物、有機酸、フェノール類Biocides are substances used to kill or inhibit all life forms when introduced in sufficient concentration and duration. Biocides are mostly used to kill harmful organisms and control bacterial or fungal growth. The biocides market is projected to register a CAGR of 4.8% between 2015 and 2020 to reach USD 10.6 billion, by 2020. Water treatment segment is estimated to be the largest application of …
- モノマー市場動向：May 2013Monomer World - May 2013 Summary Global monomer prices were relatively stable in May 2013 compared to the past few months since the beginning of 2013. Monomer supply and demand were balanced in Asia-Pacific and North America. In Europe, ethylene prices decreased spectacularly in the first half of the month; however, they recovered in the second half and traded at $100 less than April’s average pri …
- チャーチ管理ソフトウェアの世界市場2019-2023About this market The increasing number of vendors offering low-cost, trial versions of church management software will propel the market growth in the forthcoming years. Vendors are offering trial versions for providing churches a chance to try and test the software and let them decide if they want to buy it or not. Some vendors are also providing a free trial version of the software with limited …
- ユニファイドコミュニケーション（UC）の世界市場：オンプレミス型UC、ホスト型UCAbout Unified Communication UC is a system that integrates real-time communication services such as presence information, telephony, instant messaging, video conferencing, data sharing, and others, with non-real-time communication services such as unified messaging (email, SMS, and fax). It enables an individual to send messages in one medium and receive messages in another medium. For instance, o …
- オフショア・デコミッショニング（廃止）の世界市場予測（～2025年）“The offshore decommissioning market is projected to grow at a CAGR of 5.05%, from 2017 to 2025.” The offshore decommissioning market is projected to reach USD 8.76 billion by 2025, growing at a CAGR of 5.05%, from 2017 to 2025. Offshore decommissioning is plugging the oil and gas wells which are matured and are non-productive. Maturing oil and gas fields and aging infrastructure in the North Sea …
- ユーザ・プロビジョニングの世界市場予測（～2022年）The user provisioning market is projected to grow at a Compound Annual Growth Rate (CAGR) of 12.2% during the forecast periodThe global user provisioning market size is expected to grow from USD 4.25 billion in 2017 to USD 7.56 billion by 2022, at a CAGR of 12.2%. With the growing awareness of compliance management, the adoption of user provisioning and Identity and Access Management (IAM) solutio …
- Bracco Imaging S.p.A.：市場シェア分析Bracco Imaging S.p.A. Market Share Analysis Summary GlobalData’s new report, “Bracco Imaging S.p.A. Market Share Analysis” provides in-depth information on Bracco Imaging S.p.A.’s market position in the different medical equipment markets it operates in. The report provides Bracco Imaging S.p.A. market share information in one key market category – contrast media injectors. The report also provide …
